- Investing Ideas
- South Korean Pharmaceuticals & Biotech Large Cap High Growth Potential
South Korean Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
2
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
2 companies
ALTEOGEN
Market Cap: ₩19.7t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩368,500.00
7D
3.1%
1Y
5.0%
Celltrion
Market Cap: ₩42.0t
A biopharmaceutical company, engages in the development, production, and sale of development, production, and sale of medicinal products.
A068270
₩200,500.00
7D
-2.7%
1Y
29.3%